General Information of Drug (ID: DMVMYXD)

Drug Name
Adarotene ester derivative back-up compounds Drug Info
Synonyms Adarotene; Adarotene ester derivative back-up compounds (cancer); Adarotene ester derivative back-up compounds (cancer), Sigma-Tau
Cross-matching ID
TTD Drug ID
D03VUV

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
p53 signaling pathway 2.03 0.00e+0 63/73 (86.3%) CDKN1A;DDB2;TNFRSF10B;...
NF-kappa B signaling pathway 2.03 0.00e+0 90/104 (86.54%) RELB;GADD45A;CXCL8;...
RNA polymerase 1.87 1.55e-2 23/31 (74.19%) POLR2L;POLR3K;POLR1C;...
Malaria 1.81 3.02e-2 44/50 (88%) CXCL8;SDC1;CD40;...
Epstein-Barr virus infection 1.75 4.47e-2 189/202 (93.56%) CDKN1A;RELB;DDB2;...
IL-17 signaling pathway 1.74 4.34e-2 84/94 (89.36%) CXCL8;TNFAIP3;S100A8;...
Cytosolic DNA-sensing pathway 1.73 4.52e-2 52/63 (82.54%) POLR2L;NFKBIA;IRF7;...
Viral protein interaction with cytokine and cytokine re... 1.71 4.30e-2 84/100 (84%) TNFRSF10B;CXCL14;CXCL8;...
Tryptophan metabolism -1.80 3.22e-2 35/42 (83.33%) TPH1;MAOA;ALDH8A1;...
Mucin type O-glycan biosynthesis -1.81 3.43e-2 20/36 (55.56%) ST3GAL2;C1GALT1C1;ST6GALNAC2;...
PPAR signaling pathway -1.82 3.49e-2 66/74 (89.19%) CPT1A;ACOX1;APOA2;...
Starch and sucrose metabolism -1.92 2.50e-2 25/36 (69.44%) SI;HK2;GYG2;...
Carbohydrate digestion and absorption -1.99 1.07e-2 37/47 (78.72%) PLCB2;SI;PIK3CA;...
Glycolysis / Gluconeogenesis -2.03 1.07e-2 56/67 (83.58%) PDHA1;ADH7;AKR1A1;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.01uM - 10uM 24H
MDA-MB-231 CVCL_0062 Homo sapiens 0.01uM - 10uM 24H
Breast epithelium
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF-10A CVCL_0598 Homo sapiens 0.01uM - 10uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.01uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 24H
Normal (Transformed)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEK293 CVCL_0045 Homo sapiens 0.01uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.01uM - 10uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 24H
Peripheral blood
Acute monocytic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
THP-1 CVCL_0006 Homo sapiens 0.04uM - 10uM 24H
T-cell acute lymphoblastic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Jurkat CVCL_0367 Homo sapiens 0.04uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.01uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.01uM - 10uM 24H
Umbilical vein
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HUVEC-C CVCL_2959 Homo sapiens 0.01uM - 2.22uM 24H